No Detail Found!

Comparative efficacy of tocotrienol and tocopherol (vitamin E) on atherosclerotic cardiovascular diseases in humans

Author(s)
Saima Rafique Department of Pharmacology and Therapeutics, Wah Medical College, Wah Cantt, National University of Medical Sciences,Rawalpindi,Pakistan
Dilshad Ahmed Khan Department of Pathology, National University of Medical Sciences,Rawalpindi,Pakistan
Kulsoom Farhat Department of Pharmacology and Therapeutics, Army Medical College, National University of Medical Sciences, Rawalpindi,Pakistan
Muhammad Asghar Khan National University of Medical Sciences,Rawalpindi, Pakistan
Mudassar Noor Department of Pharmacology and Therapeutics, Army Medical College, National University of Medical Sciences, Rawalpindi,Pakistan
Mahjabeen Sharif Department of Pharmacology and Therapeutics, Army Medical College, National University of Medical Sciences, Rawalpindi,Pakistan
Abstract
Objective: TTo compare the efficacy of tocotrienol and tocopherol in the management of patients with atherosclerotic cardiovascular diseases. Method: The systematic review was conducted in line with Preferred Reporting Items for Systematic Reviews and MetaAnalyses guidelines 2020, and comprised literature search from 2002 till January 5, 2023, on PubMed, Google Scholar, Cochrane Library, Google, Wiley-Inter Science Library, Medline, SpringerLink, Taylor and Francis databases. The search was conducted using key words, such as: “tocopherol”, “tocotrienol”, “vitamin E”, “dyslipidaemia”, “cardiovascular diseases” “cardioprotective”, “hypercholesterolemia” and “atherosclerosis” along with Boolean operators. Human clinical studies regarding the use of tocotrienol or tocopherol or comparison of its efficacy in patients having atherosclerosis, dyslipidaemia leading to cardiovascular diseases, and studies including details of efficacy of any of the four alpha, beta, gamma, delta isomers of tocopherol or tocotrienol were included. Pertinent data from the eligible studies was retrieved and reviewed. Results: Of the 516 articles identifi ed, 26 (5%) articles met eligibility criteria. Of them 5(19%) were subjected to detailed analysis. Tocotrienol showed signifi cant anti-oxidant efficacy at (250 mg/d) by decreasing cholesterol and serum infl ammatory biomarkers i.e C-reactive protein (40%), malondialdehyde (34%), gamma-glutamyl transferase (22%) (p<0.001). Total anti-oxidant status (TAS) levels raised 22% (p<0.001) and Infl ammatory cytokines i.e resistin, interleukin (IL)-1, IL-12, Interferon-gamma were decreased 15-17% (p<0.05-0.01) respectively by tocotrienol. Several microRNA (miRNA-133a, miRNA-223, miRNA-214, miRNA-155) were modulated by d-tocotrienol. Whereas, tocopherol showed heterogeneity of results by either decreasing or increasing the risk of mortality in atherosclerotic cardiovascular diseases. Conclusion: Compared to tocopherol, tocotrienol was found to be safe and potential candidate for improving cardiovascular health in the management of atherosclerotic cardiovascular diseases.
Publication Details
Page(s) 1124-1129
Published Journal: Journal of Pakistan Medical Association, Volume: 74, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
atherosclerosis, Vitamin E, tocopherol, Cardiovascular Diseases, dyslipidaemia, Tocotrienol
0

Citations

0

Downloads

73

Views